OpenEMR up to 8.2.x Template Import cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.8 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, was found in OpenEMR up to 8.2.x. The impacted element is an unknown function of the component Template Import Handler. Executing a manipulation can lead to cross site scripting. This vulnerability is handled as CVE-2026-40508. The attack can be executed remotely. There is not any exploit available.
Details
A vulnerability was found in OpenEMR up to 8.2.x. It has been declared as problematic. This vulnerability affects some unknown functionality of the component Template Import Handler. The manipulation with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
OpenEMR before 8.3.0 contains a stored cross-site scripting vulnerability in the patient portal template import handler that allows authenticated attackers with Forms Administration permissions to upload template files containing arbitrary HTML or JavaScript. Attackers can inject malicious scripts through the template upload functionality, which are stored without sanitization and execute in the browser of any other Forms Administration user who views the template in the HTML editor.
The advisory is shared for download at github.com. This vulnerability was named CVE-2026-40508 since 04/13/2026. The exploitation appears to be easy. The attack can be initiated remotely. The exploitation needs additional levels of successful authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
Upgrading to version 8.3.0 eliminates this vulnerability.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Name
Version
License
Website
- Product: https://github.com/openemr/openemr/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 3.9VulDB Meta Temp Score: 3.8
VulDB Base Score: 2.4
VulDB Temp Score: 2.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.4
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: OpenEMR 8.3.0
Timeline
04/13/2026 CVE reserved08/19/2026 Advisory disclosed
08/19/2026 VulDB entry created
08/19/2026 VulDB entry last update
Sources
Product: github.comAdvisory: github.com
Status: Confirmed
CVE: CVE-2026-40508 (🔒)
GCVE (CVE): GCVE-0-2026-40508
GCVE (VulDB): GCVE-100-393136
Entry
Created: 08/19/2026 17:08Changes: 08/19/2026 17:08 (76)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.